Bridging adjuvant treatment gaps: low and intermediate risk endometrial carcinoma patients care in Salah Azaiez Institute in Tunisia.

ABSTRACT:

Background

The management of low- and intermediate-risk endometrial carcinoma (EC) at the Salah Azaiez Institute (SAI) has evolved with international recommendations and the advent of the molecular era. We lack access to molecular profiling; consequently, both undertreatment and overtreatment are observed. This study explores how adherence to international recommendations affects clinical outcomes.

Methods

We performed a retrospective analytic study including 180 women with stage I-II low-, low-intermediate-, and high-intermediate-risk EC treated at SAI between 2015 and 2020, with at least 3 years of follow-up. Ethical approval and patient consent were obtained; for telephone interviews, verbal consent was secured. We selected 60 women per risk group from a larger pool to en

SUBMITTER: Boudhina E 

PROVIDER: S-EPMC12470651 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature